SCHEMBL5196161

SCHEMBL5196161

Cc1ccc(C(=O)N(C)c2nc(-c3ccccc3)sc2OC(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.46
▸ NPC1 O15118 5/20 0.46
▸ LMNA P02545 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ TRPM8 Q7Z2W7 1/20 0.42
▸ RARA P10276 2/20 0.41
▸ RARB P10826 2/20 0.41
▸ RARG P13631 2/20 0.41
▸ ALOX5 P09917 2/20 0.41
▸ GRM1 Q13255 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5196165 0.89 MAPT (0.45) RAB9ANPC1LMNAKMT2APOLB
SCHEMBL5194116 0.85 USP2 (0.40) RAB9ANPC1LMNAKMT2ATRPM8
SCHEMBL5196153 0.83 SMN1; SMN2 (0.55) RAB9ANPC1LMNAKMT2APOLB
SCHEMBL5197734 0.80 POLB (0.49) RAB9ANPC1KMT2APOLBTRPM8
SCHEMBL5193911 0.79 RAB9A (0.42) RAB9ANPC1LMNAKMT2APOLB
SCHEMBL5195687 0.77 CYP1A2 (0.47) RAB9ANPC1KMT2APOLBTRPM8
SCHEMBL3816560 0.75 HSD17B1 (0.44) RAB9ANPC1LMNAKMT2APOLB
SCHEMBL13685249 0.73 SMN1; SMN2 (0.61) RAB9ANPC1LMNAKMT2ATRPM8
SCHEMBL5196876 0.72 SMN1; SMN2 (0.53) RAB9ANPC1LMNAKMT2APOLB
SCHEMBL14430682 0.71 SMN1; SMN2 (0.52) RAB9ANPC1LMNAKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1321463-B1 Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections VIROCHEM PHARMA INC (CA) 2007-08-08 — — EP claimed
Send feedback